Convective renal replacement therapies for acute renal failure and end-stage renal disease

Zhongping Huang, Baochun Li, Weiming Zhang, Dayong Gao, Michael Kraus, William R. Clark

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Although hemodialysis remains the primary treatment modality for the management of patients with end-stage renal disease (ESRD), its clearance of relatively large-sized uremic toxins is limited due to its primarily diffusive nature. Moreover, recent studies suggesting conventional, diffusion-based therapies may be limited in their ability to influence outcome in ESRD patients indicate the need for alternative chronic dialysis approaches, an example of which is convective therapies. In an analogous manner, a reassessment of the dialytic management of critically ill patients with acute renal failure (ARF) has also occurred recently based on clinical evidence that high-dose continuous hemofiltration improves survival. These recent clinical results suggest the utilization of convective therapies in both ARF and ESRD will increase in the future. This article provides a review of convective therapies, with an initial discussion of the determinants of convective solute removal. This is followed by a comprehensive overview of the manner in which hemofiltration and hemodiafiltration are applied clinically.

Original languageEnglish
Pages (from-to)386-393
Number of pages8
JournalHemodialysis International
Volume8
Issue number4
DOIs
StatePublished - Oct 2004

Fingerprint

Renal Replacement Therapy
Acute Kidney Injury
Chronic Kidney Failure
Hemofiltration
Hemodiafiltration
Therapeutics
Critical Illness
Renal Dialysis
Dialysis
Survival

Keywords

  • Hemodiafiltration
  • Hemodialysis
  • Hemofiltration
  • Solute
  • Ultrafiltration

ASJC Scopus subject areas

  • Hematology

Cite this

Convective renal replacement therapies for acute renal failure and end-stage renal disease. / Huang, Zhongping; Li, Baochun; Zhang, Weiming; Gao, Dayong; Kraus, Michael; Clark, William R.

In: Hemodialysis International, Vol. 8, No. 4, 10.2004, p. 386-393.

Research output: Contribution to journalArticle

Huang, Zhongping ; Li, Baochun ; Zhang, Weiming ; Gao, Dayong ; Kraus, Michael ; Clark, William R. / Convective renal replacement therapies for acute renal failure and end-stage renal disease. In: Hemodialysis International. 2004 ; Vol. 8, No. 4. pp. 386-393.
@article{47dd8e83b5ce49bc9ff157c51ac57337,
title = "Convective renal replacement therapies for acute renal failure and end-stage renal disease",
abstract = "Although hemodialysis remains the primary treatment modality for the management of patients with end-stage renal disease (ESRD), its clearance of relatively large-sized uremic toxins is limited due to its primarily diffusive nature. Moreover, recent studies suggesting conventional, diffusion-based therapies may be limited in their ability to influence outcome in ESRD patients indicate the need for alternative chronic dialysis approaches, an example of which is convective therapies. In an analogous manner, a reassessment of the dialytic management of critically ill patients with acute renal failure (ARF) has also occurred recently based on clinical evidence that high-dose continuous hemofiltration improves survival. These recent clinical results suggest the utilization of convective therapies in both ARF and ESRD will increase in the future. This article provides a review of convective therapies, with an initial discussion of the determinants of convective solute removal. This is followed by a comprehensive overview of the manner in which hemofiltration and hemodiafiltration are applied clinically.",
keywords = "Hemodiafiltration, Hemodialysis, Hemofiltration, Solute, Ultrafiltration",
author = "Zhongping Huang and Baochun Li and Weiming Zhang and Dayong Gao and Michael Kraus and Clark, {William R.}",
year = "2004",
month = "10",
doi = "10.1111/j.1492-7535.2004.80415.x",
language = "English",
volume = "8",
pages = "386--393",
journal = "Hemodialysis International",
issn = "1492-7535",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Convective renal replacement therapies for acute renal failure and end-stage renal disease

AU - Huang, Zhongping

AU - Li, Baochun

AU - Zhang, Weiming

AU - Gao, Dayong

AU - Kraus, Michael

AU - Clark, William R.

PY - 2004/10

Y1 - 2004/10

N2 - Although hemodialysis remains the primary treatment modality for the management of patients with end-stage renal disease (ESRD), its clearance of relatively large-sized uremic toxins is limited due to its primarily diffusive nature. Moreover, recent studies suggesting conventional, diffusion-based therapies may be limited in their ability to influence outcome in ESRD patients indicate the need for alternative chronic dialysis approaches, an example of which is convective therapies. In an analogous manner, a reassessment of the dialytic management of critically ill patients with acute renal failure (ARF) has also occurred recently based on clinical evidence that high-dose continuous hemofiltration improves survival. These recent clinical results suggest the utilization of convective therapies in both ARF and ESRD will increase in the future. This article provides a review of convective therapies, with an initial discussion of the determinants of convective solute removal. This is followed by a comprehensive overview of the manner in which hemofiltration and hemodiafiltration are applied clinically.

AB - Although hemodialysis remains the primary treatment modality for the management of patients with end-stage renal disease (ESRD), its clearance of relatively large-sized uremic toxins is limited due to its primarily diffusive nature. Moreover, recent studies suggesting conventional, diffusion-based therapies may be limited in their ability to influence outcome in ESRD patients indicate the need for alternative chronic dialysis approaches, an example of which is convective therapies. In an analogous manner, a reassessment of the dialytic management of critically ill patients with acute renal failure (ARF) has also occurred recently based on clinical evidence that high-dose continuous hemofiltration improves survival. These recent clinical results suggest the utilization of convective therapies in both ARF and ESRD will increase in the future. This article provides a review of convective therapies, with an initial discussion of the determinants of convective solute removal. This is followed by a comprehensive overview of the manner in which hemofiltration and hemodiafiltration are applied clinically.

KW - Hemodiafiltration

KW - Hemodialysis

KW - Hemofiltration

KW - Solute

KW - Ultrafiltration

UR - http://www.scopus.com/inward/record.url?scp=21644459442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21644459442&partnerID=8YFLogxK

U2 - 10.1111/j.1492-7535.2004.80415.x

DO - 10.1111/j.1492-7535.2004.80415.x

M3 - Article

VL - 8

SP - 386

EP - 393

JO - Hemodialysis International

JF - Hemodialysis International

SN - 1492-7535

IS - 4

ER -